Position in MRK
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$491,512
-$44,019 QoQ
Shares Held
3,825
-14.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#2,710
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Princeton Global Asset Management LLC holds $25,670,962 across 14 Drug Manufacturers - General names. MRK ranks #4 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
41,882 | $10,636,771 | |
| 2 | LLY |
ELI LILLY & Co
|
5,815 | $6,974,686 | |
| 3 | ABBV |
AbbVie Inc.
|
26,493 | $6,666,698 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
3,825 | $491,512 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
1,594 | $201,385 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
3,450 | $198,789 | |
| 7 | AMGN |
Amgen Inc
|
499 | $180,697 | |
| 8 | AZN |
Astrazeneca PLC
|
828 | $157,005 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $491,512 | 3,825 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $535,531 | 4,452 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $467,985 | 4,446 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $252,293 | 3,006 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $268,827 | 3,396 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $843,205 | 9,394 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $1,341,686 | 13,487 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $2,791,531 | 24,582 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $2,940,869 | 23,755 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $2,208,843 | 16,740 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $1,876,125 | 17,209 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $1,859,791 | 18,065 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $2,210,295 | 19,155 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $3,744,396 | 35,195 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $3,875,372 | 34,929 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $3,039,949 | 35,299 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,277,470 | 35,949 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $2,974,230 | 36,249 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $2,789,466 | 36,397 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $2,746,998 | 36,573 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $2,858,514 | 36,756 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $2,763,832 | 35,852 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $2,934,410 | 35,873 | Shares | Sole | 2021-02-09 | |
| 2020-09-30 | $2,296,637 | 27,687 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $2,253,087 | 29,136 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $233,589 | 3,036 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||